Jacobson Pharma Corporation Limited (HKG:2633)

HKG:2633 Balance Sheet

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	515.9	411.94	1,036	478.65	480.35	417.99
Short-Term Investments	47.89	46.24	52.1	51.43	43.06	70.35
Trading Asset Securities	-	-	-	-	-	7.69
Cash & Short-Term Investments	563.79	458.17	1,089	530.08	523.41	496.03
Cash Growth	-38.13%	-57.91%	105.35%	1.27%	5.52%	-28.04%
Accounts Receivable	174.02	172.83	288.23	308.94	260.99	199.91
Other Receivables	18.26	15.55	12.66	24.67	20.19	24.48
Receivables	192.28	188.39	300.89	333.61	281.19	224.39
Inventory	325.93	317.86	368	314.56	356.18	371.46
Other Current Assets	-	-	-	-	-	78.5
Total Current Assets	1,082	964.42	1,757	1,178	1,161	1,170
Property, Plant & Equipment	1,308	1,301	1,502	1,504	1,551	1,135
Long-Term Investments	460.91	481.51	569.77	471.03	519.86	492.73
Goodwill	-	183.72	450.57	444.26	444.26	412.02
Other Intangible Assets	430.09	187.54	805.1	805.19	851.93	849.97
Long-Term Deferred Tax Assets	10.73	10.85	10.23	10.16	10.26	10.08
Long-Term Deferred Charges	-	64.59	64.41	53.73	48.88	48.89
Other Long-Term Assets	315.06	292.8	220.87	289.16	280.57	460.66
Total Assets	3,607	3,487	5,380	4,756	4,867	4,580
Accounts Payable	41.36	51.69	80.25	50.46	38.59	36.02
Accrued Expenses	84.67	53.66	58.32	51.59	42.05	42.98
Current Portion of Long-Term Debt	148	112.8	309.55	612.18	685.91	538.65
Current Portion of Leases	23.63	26.87	34.82	33.97	35.94	47.45
Current Income Taxes Payable	43.2	16.7	28.41	20.83	14.33	10.35
Current Unearned Revenue	58.14	60.88	54.89	3.74	3.43	6.54
Other Current Liabilities	117.49	50.24	90.21	53.62	53.65	45.37
Total Current Liabilities	516.49	372.84	656.44	826.38	873.91	727.36
Long-Term Debt	504.4	592.2	1,234	729.47	892.21	1,015
Long-Term Leases	23.82	17.51	20.53	34.32	34.56	47.04
Long-Term Deferred Tax Liabilities	106.23	107.94	212.86	207.4	206.36	184.72
Total Liabilities	1,151	1,090	2,124	1,798	2,007	1,974
Common Stock	19.86	19.8	19.08	19.16	19.16	19.17
Additional Paid-In Capital	1,038	1,038	999.9	999.9	999.9	999.9
Retained Earnings	1,082	1,002	1,468	1,381	1,230	1,385
Comprehensive Income & Other	291.79	312.19	250.09	91.22	140.6	133.23
Total Common Equity	2,432	2,372	2,737	2,491	2,390	2,538
Minority Interest	24.22	24.22	519.83	466.65	470.26	68.35
Shareholders' Equity	2,456	2,396	3,257	2,958	2,860	2,606
Total Liabilities & Equity	3,607	3,487	5,380	4,756	4,867	4,580
Total Debt	699.85	749.38	1,599	1,410	1,649	1,648
Net Cash (Debt)	-136.06	-291.21	-510.54	-879.86	-1,125	-1,152
Net Cash Per Share	-0.07	-0.15	-0.27	-0.46	-0.59	-0.58
Filing Date Shares Outstanding	1,986	1,980	1,908	1,916	1,916	1,917
Total Common Shares Outstanding	1,986	1,980	1,908	1,916	1,916	1,917
Working Capital	565.51	591.57	1,101	351.86	286.88	443.02
Book Value Per Share	1.22	1.20	1.43	1.30	1.25	1.32
Tangible Book Value	2,001	2,001	1,481	1,242	1,094	1,276
Tangible Book Value Per Share	1.01	1.01	0.78	0.65	0.57	0.67
Land	-	115.94	127.43	103.06	102.34	66.08
Buildings	-	1,036	1,130	1,078	1,058	599.04
Machinery	-	908.37	1,018	1,002	973.99	950.85
Leasehold Improvements	-	40.63	42.25	45.58	36.39	28.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.